Specialized compound could lead to chronic pain relief without the use of opioids
Purdue researchers have discovered a compound that could lead to the treatment of chronic pain without the need for patients to rely on opioids.
Mar 14, 2017
0
462
Purdue researchers have discovered a compound that could lead to the treatment of chronic pain without the need for patients to rely on opioids.
Mar 14, 2017
0
462
(Medical Xpress)—Cancer painfully ends more than 500,000 lives in the United States each year, according to the Centers for Disease Control and Prevention. The scientific crusade against cancer recently achieved a victory ...
Apr 3, 2013
6
1
RIKEN researchers have determined how a protein that transports essential amino acids across the placenta contributes to normal embryonic development in mammals.
Dec 27, 2019
0
342
Researchers at the University of Illinois Chicago have designed a high-quality assay that can be used in at-home tests for rapid COVID-19 screening. Results from an early preclinical study suggest that tests with the new ...
Jan 3, 2022
0
186
People with multiple sclerosis (MS) gradually develop increasing functional impairment. Researchers at Karolinska Institutet have now found a possible explanation for the progressive course of the disease in mice and how ...
Oct 16, 2020
0
280
Blood vessels must adapt their growth to the nutrients available in their surroundings so that they can keep organs adequately supplied. A team led by Michael Potente has identified two proteins that are important for this ...
Jun 20, 2022
0
56
Treatments for chronic inflammatory diseases are one step closer as University of Queensland researchers discover a way to stop inflammation in its tracks.
May 13, 2019
0
440
A study published in Current Biology reports on one of the first comprehensive characterizations of poorly formed memories, and may offer a framework to explore different therapeutic approaches to fear, memory and anxiety ...
May 21, 2020
0
865
Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered the mechanism by which a low dose of the opioid antagonist naltrexone (LDN), an agent used clinically (off-label) ...
Sep 2, 2011
0
0
Imagine a single drug that would treat most, if not all, autoimmune disorders, such as asthma, inflammatory bowel disease, and Lupus. That might not be so hard to do thanks to a team of researchers who have discovered a molecule ...
Sep 29, 2011
0
0